Dr. Mary D. Chamberlin
Claim this profileDartmouth Hitchcock Medical Center
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
15 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER positive
2Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Mary D. Chamberlin is currently running
TPIV100 + Sargramostim
for Breast Cancer
This trial tests a vaccine and a drug in patients with a specific type of breast cancer who still have cancer after chemotherapy. The vaccine helps the immune system target cancer cells, and the drug boosts white blood cells to strengthen this response. The goal is to see if this combination can better treat these patients.
Recruiting0 awards Phase 238 criteria
Vaccine + Chemotherapy + Immunotherapy
for Breast Cancer
This phase II trial studies how well nab-paclitaxel, durvalumab, and tremelimumab with or without personalized synthetic long peptide vaccine (neoantigen vaccine) works in treating patients with triple negative breast cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as durvalumab and tremelimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. It is not yet known whether giving nab-paclitaxel, durvalumab, and tremelimumab with or without neoantigen vaccine will work better in treating patients with triple negative breast cancer.
Recruiting1 award Phase 222 criteria
More about Mary D. Chamberlin
Clinical Trial Related8 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Mary D. Chamberlin has experience with
- Letrozole
- Radium-223 Dichloride
- Paclitaxel
- Cisplatin
- Carboplatin
- Nab-paclitaxel
Breakdown of trials Mary D. Chamberlin has run
Breast Cancer
Cancer
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary D. Chamberlin specialize in?
Mary D. Chamberlin focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Mary D. Chamberlin currently recruiting for clinical trials?
Yes, Mary D. Chamberlin is currently recruiting for 4 clinical trials in Lebanon New Hampshire. If you're interested in participating, you should apply.
Are there any treatments that Mary D. Chamberlin has studied deeply?
Yes, Mary D. Chamberlin has studied treatments such as Letrozole, Radium-223 Dichloride, Paclitaxel.
What is the best way to schedule an appointment with Mary D. Chamberlin?
Apply for one of the trials that Mary D. Chamberlin is conducting.
What is the office address of Mary D. Chamberlin?
The office of Mary D. Chamberlin is located at: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756 United States. This is the address for their practice at the Dartmouth Hitchcock Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.